GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$91.34 USD
+0.52 (0.57%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $91.35 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$91.34 USD
+0.52 (0.57%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $91.35 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Zacks News
GE HealthCare's Shares Rise After the Launch of Versana Premier
by Zacks Equity Research
GEHC launches Versana Premier, an AI-powered ultrasound system with advanced features designed for efficient, high-quality diagnostics across multiple specialties.
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe
by Zacks Equity Research
ATRC's EnCompass Clamp receives a CE Mark, enabling European surgeons to access faster, simpler heart ablation in cardiac surgeries with advanced radiofrequency technology.
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business
by Zacks Equity Research
GEHC acquires clinical AI business to aid its ultrasound portfolio with AI-driven image analysis tools.
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
by Zacks Equity Research
GE Healthcare's MIM Software announces the FDA clearance of Monte Carlo Dosimetry for Theranostics, enhancing precision in personalized treatment plans.
InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent
by Zacks Equity Research
NSPR gains premarket approval for its CGuard Prime carotid stent system for use in United States for treating carotid artery stenosis.
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
by Zacks Equity Research
GEHC's continued focus on innovations, acquisitions and partnerships raise optimism about the stock.
GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
by Zacks Equity Research
GEHC's Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.
GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch
by Zacks Equity Research
GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.
GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool
by Zacks Equity Research
GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.
Can Cloud Momentum Drive Amazon's Stock Beyond Its 14.1% YTD Gain?
by Shilpa Mete
Amazon rides on AWS strength, driven by an expanding portfolio, a strong customer base and its Generative AI drive.
GE Healthcare to Unveil AI-Driven Cardiac Diagnostics at ESC 2024
by Zacks Equity Research
GEHC launches AI-enhanced ultrasound and ECG-less Cardiac CT technologies, offering rapid, accurate cardiac diagnostics at the point of care.
GE HealthCare's (GEHC) Tie-Up to Boost Female Pelvic Healthcare
by Zacks Equity Research
GE HealthCare's (GEHC) latest collaboration is likely to equip clinicians with a toolset to deliver enhanced care to female patients and improve the patient experience.
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GE HealthCare (GEHC) Q2 Earnings Beat Estimates, Net Margin Up
by Zacks Equity Research
GE HealthCare's (GEHC) second-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.
Here's What Key Metrics Tell Us About GE HealthCare (GEHC) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GE HealthCare Technologies (GEHC) Tops Q2 Earnings Estimates
by Zacks Equity Research
GE HealthCare (GEHC) delivered earnings and revenue surprises of 2.04% and 1.03%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?
by Indrajit Bandyopadhyay
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, XRAY, GEHC and GKOS are placed ahead of their earnings release.
Lower Volume Likely to Hurt GE HealthCare's (GEHC) Q2 Earnings
by Zacks Equity Research
GE HealthCare's (GEHC) second-quarter results are likely to witness declining segmental revenues in imaging, ultrasound and patient care. The bottom-line results may reflect better pricing.
GE HealthCare (GEHC) New Deal to Aid Its Ultrasound Portfolio
by Zacks Equity Research
GE HealthCare (GEHC) announces that it has entered into an agreement to acquire Intelligent Ultrasound's AI software business to strengthen its ultrasound portfolio.
Top Analyst Reports for Berkshire Hathaway, McDonald's & American Express
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), McDonald's Corporation (MCD) and American Express Company (AXP), as well as a micro-cap stock Steel Partners Holdings L.P. (SPLP).
GE HealthCare's (GEHC) New Solution to Aid Prostate Treatment
by Zacks Equity Research
GE HealthCare's (GEHC) MIM Software introduced the MIM Symphony HDR Prostate to provide direct tumor visualization using MRI images during live ultrasound procedures for HDR prostate treatments.
GE Healthcare (GEHC) Enters Partnership to Boost MRI Technology
by Zacks Equity Research
GE Healthcare's (GEHC) alliance is likely to establish an Innovative MRI Research and Development center to advance MRI innovation and patient care
GE HealthCare's (GEHC) New Tie-Up to Boost CVD Workflow
by Zacks Equity Research
GE HealthCare's (GEHC) latest collaboration is likely to enable clinicians to perform complex cardiology interventions with a high level of precision and improved image quality.
GE HealthCare (GEHC) Boosts Interventional Radiology Capabilities
by Zacks Equity Research
GE HealthCare's (GEHC) latest successful first installation and clinical cases using the OmnifyXR are likely to improve clinical and operational outcomes for both patients and clinicians.
3 Generative AI-Based MedTech Stocks to Keep an Eye On
by Moumi Mondal
With the growing influence of GenAI in the MedTech sector, innovators like ZBH, GEHC and MDT are poised to thrive.